Translating scientific advances into disease-modifying therapies for Parkinson's Disease

Exp Neurol. 2017 Dec;298(Pt B):135-136. doi: 10.1016/j.expneurol.2017.10.011.

Authors

M Angela Cenci¹, C Warren Olanow²

Affiliations

¹ Basal Ganglia Pathophysiology Unit, Dept. Exp. Med. Science, Lund University, Lund (Sweden).
² Clintrex LLC; Department of Neurology and Department of Neurosciences, Mount Sinai School of Medicine, New York.

PMID: 29145992
DOI: 10.1016/j.expneurol.2017.10.011

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Antiparkinson Agents / therapeutic use*
Biomedical Research / methods
Biomedical Research / trends*
Humans
Parkinson Disease / diagnosis
Parkinson Disease / drug therapy*

Substances

Antiparkinson Agents